title: 5-Aza-2'-deoxycytidine (decitabine) treatment of hematopoietic malignancies: a multimechanism therapeutic approach?
authors.forename: Luca
authors.initials: L
authors.lastname: Sigalotti
authors.forename: Maresa
authors.initials: M
authors.lastname: Altomonte
authors.forename: Francesca
authors.initials: F
authors.lastname: Colizzi
authors.forename: Massimo
authors.initials: M
authors.lastname: Degan
authors.forename: Maurizio
authors.initials: M
authors.lastname: Rupolo
authors.forename: Vittorina
authors.initials: V
authors.lastname: Zagonel
authors.forename: Antonio
authors.initials: A
authors.lastname: Pinto
authors.forename: Valter
authors.initials: V
authors.lastname: Gattei
authors.forename: Michele
authors.initials: M
authors.lastname: Maio
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000627:therapeutic use; D019175:DNA Methylation / Q000187:drug effects; D000077209:Decitabine; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000235:genetics
chemical_list: D009363:Neoplasm Proteins; D000077209:Decitabine; D001374:Azacitidine